Press
Two-Year Results Demonstrating Long-Term Effectiveness of Aerin Medical’s VivAer® Treatment of Nasal Obstruction Published in International Forum of Allergy & Rhinology
April 21, 2021
Aerin Medical today announced the publication of two-year results from a multi-center, prospective study that demonstrate significant, long-term relief for nasal obstruction sufferers who underwent treatment of nasal valve collapse with VivAer®.
Aerin Medical Announces Appointment of Matt Brokaw as President and CEO
August 17, 2020
Aerin Medical, a privately held medical device company focused on non-invasive procedures for treating nasal airway conditions, today announced the closing of a $48 million equity financing.
Aerosol Generation with Common Rhinologic Devices: Cadaveric Study Conducted in a Surgical Suite
August 2020
Aerosol-generating medical procedures present potential risk to practitioners, particularly during the SARS CoV-2 (COVID-19) pandemic.
Quality-of-life impact after in-office treatment of nasal valve obstruction with a radiofrequency device
August 2020
Chronic nasal obstruction contributes to a decreased quality of life. Nasal valve dysfunction is increasingly recognized as a cause of nasal obstruction.
Aerin Medical Announces FDA Clearance and U.S. Launch of Innovative Nonsurgical Procedure for Chronic Rhinitis
March 6th, 2020
RhinAer™ Procedure Promises Lasting Relief for Millions of Americans Suffering from Common Chronic Condition
New Non-Invasive Technique Promises Hope For Troubled Breathing
May 6th, 2019
Judging by all the ads for things from nasal strips to sprays to medications, there are a lot of people who have trouble breathing.
Non-Invasive Nasal Procedure Helps Patients Breathe Easier in Minutes
February 13th, 2019
Dr. Michelle Putnam recommended the Vivaer® Nasal Airway Remodeling treatment to reduce swelling of the lateral nasal wall.
In‐office Treatment of Nasal Valve Obstruction Using a Novel, Bipolar Radiofrequency Device
February 4th, 2019
Vivaer® Nasal Airway Remodeling pivotal study published in Laryngoscope Investigative Otolaryngology: A prospective, multi-center, non-randomized US Pivotal Study to evaluate the treatment of nasal airway obstruction using the Vivaer® System demonstrated outstanding patient outcomes.
New Solution to Breathing Problems Available in Alabama
February 1st, 2019
A new procedure to fix patients’ breathing problems is being offered in Alabama.
Non-randomized Evaluation of a Novel Low Energy Radiofrequency Treatment for Nasal Obstruction and Snoring
January 3rd, 2019
A prospective, non-randomized study using Vivaer® to treat nasal obstruction and snoring was conducted in Germany by Drs. Detlef Brehmer, Robert Bodlaj and Friedemann Gerhards.
WCNC Welcomes Dr. Daron Smith from Cornerstone ENT
October 8th, 2018
Dr. Daron Smith discusses the Vivaer® Nasal Airway Remodeling and benefits of better nasal breathing.
Tony Vanetti of WHAS Goes Under the Vivaer® Stylus
August 24th, 2018
Tony Vanetti, a host at WHAS television in Louisville, KY has the Vivaer® Nasal Airway Remodeling procedure performed.
Aerin Medical Achieves Significant Milestone with over 1,000 Patients Treated with VIVAER
July 31st, 2018
Aerin Medical, Inc. (“Aerin”) announced that over 1,000 patients suffering from nasal obstruction have successfully received the Vivaer® Nasal Airway Remodeling treatment (“Vivaer®“) which uses patented non-invasive low temperature radio frequency technology to reshape nasal tissues.
New Treatment for Nasal Airway Obstruction
May 23rd, 2018
Dr. Bradley Otto of Ohio State University Wexner Medical Center’s Division of Otolaryngology talks about Vivaer® Nasal Airway Remodeling.
Aerin Launching a Novel Non-invasive Solution for Nasal Airway Obstruction
January 9th, 2018
Aerin Medical, Inc. (“Aerin”) announced that it has received regulatory clearance for its novel Vivaer® Non-Invasive Airway Remodeling System (“Vivaer®“), a product developed to enable Ear, Nose & Throat (“ENT”) physicians to treat nasal airway obstruction within their physician office without the need for incisions or implants.
WEB948-15.A